News

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The United States will restrict routine Covid-19 boosters to people over 65 or those at higher risk of serious illness, while ...
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...